A Clinical Trial Testing the Safety of Pumitamig (an Investigational Drug) and How Well it Works When Combined With Chemotherapy for People Who Have Not Been Treated Yet for Pancreatic Cancer

Clinical trial NCT07255404 · RECRUITING

Trial details

NCT number: NCT07255404
Sponsor: BioNTech SE
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pancreatic Ductal Adenocarcinoma (PDAC)

Start date: 2025-12-04
Primary completion: 2027-12-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.